Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TVTX

Travere Therapeutics Inc

May 29 • 04:00PM ET

47.18

-0.58 -1.21 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: MIRM PTCT RYTM BMRN IONS KRYS ALNY AXSM INCY NAMS

| Held by: XBI VTI IWM VXF IBB IWO SCHA VTWO PJP VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.53	Insider Own	2.84%	Shs Outstand	92.40M	Perf Week	5.45%
Market Cap	4.39B	Forward P/E	18.76	EPS next Y	2.51	Insider Trans	-23.43%	Shs Float	90.35M	Perf Month	17.66%
Enterprise Value	4.45B	PEG	-	EPS next Q	-0.05	Inst Own	110.37%	Short Float	15.50%	Perf Quarter	58.38%
Income	-45.64M	P/S	8.18	EPS this Y	216.32%	Inst Trans	-2.87%	Short Ratio	6.52	Perf Half Y	31.02%
Sales	536.20M	P/B	44.16	EPS next Y	645.53%	ROA	-8.27%	Short Interest	14.01M	Perf YTD	23.48%
Book/sh	1.07	P/C	16.58	EPS next 5Y	-	ROE	-69.38%	52W High	48.61 -2.94%	Perf Year	206.76%
Cash/sh	2.85	P/FCF	110.77	EPS past 3/5Y	49.47% 30.85%	ROIC	-10.86%	52W Low	13.88 239.91%	Perf 3Y	187.33%
Dividend Est.	-	EV/EBITDA	276.59	Sales past 3/5Y	64.89% 19.87%	Gross Margin	84.94%	Volatility	4.56% 5.24%	Perf 5Y	211.01%
Dividend TTM	-	EV/Sales	8.30	EPS Y/Y TTM	82.27%	Oper. Margin	-10.64%	ATR (14)	2.13	Perf 10Y	170.06%
Dividend Ex-Date	-	Quick Ratio	3.08	Sales Y/Y TTM	96.03%	Profit Margin	-8.51%	RSI (14)	66.94	Recom	1.13
Dividend Gr. 3/5Y	- -	Current Ratio	3.13	EPS Q/Q	14.62%	SMA20	6.47%	Beta	1.14	Target Price	54.14
Payout	-	Debt/Eq	3.32	Sales Q/Q	55.63%	SMA50	23.42%	Rel Volume	1.01	Prev Close	47.76
Employees	497	LT Debt/Eq	3.26	Earnings	May 04 AMC	SMA200	50.05%	Avg Volume	2.15M	Price	47.18
IPO	Oct 06, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	-65.29% -6.63%	Trades		Volume	2,175,986	Change	-1.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)